Adiposity and sex hormones in girls

Cancer Epidemiology Biomarkers and Prevention

Volumn 16, Issue 9, 2007, Pages 1880-1888

  Baer, Heather J ^a,b,e   Colditz, Graham A ^c   Willett, Walter C ^a,b   Dorgan, Joanne F ^d  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c USA   (United States)

^d FOX CHASE CANCER CENTER   (United States)

^e CHANNING LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ESTROGEN; PRASTERONE SULFATE; PROGESTERONE; SEX HORMONE; SEX HORMONE BINDING GLOBULIN;

ANDROGEN BLOOD LEVEL; ANTHROPOMETRY; ARTICLE; BLOOD SAMPLING; BODY MASS; CONTROLLED STUDY; FEMALE; FOLLOW UP; HORMONE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MENARCHE; OBESITY; PRIORITY JOURNAL; SCHOOL CHILD; WAIST CIRCUMFERENCE;

ADIPOSITY; ADOLESCENT; ANTHROPOMETRY; BODY MASS INDEX; BREAST NEOPLASMS; CHILD; DEHYDROEPIANDROSTERONE SULFATE; FEMALE; FOLLOW-UP STUDIES; GONADAL STEROID HORMONES; HUMANS; PREMENOPAUSE; PROSPECTIVE STUDIES; RISK FACTORS; SEX HORMONE-BINDING GLOBULIN; TIME FACTORS;

EID: 34548858423     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-07-0313     Document Type: Article

References (63)

1. van den Brandt PA, Spiegelman D, Yaun SS, et al. Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol 2000;152:514-27.
2. Friedenreich CM. Review of anthropometric factors and breast cancer risk. Eur J Cancer Prev 2001;10:15-32.
3. Le Marchand L, Kolonel LN, Earle ME, Mi MP. Body size at different periods of life and breast cancer risk. AmJ Epidemiol 1988;128:137-52.
4. Hilakivi-Clarke L, Forsen T, Eriksson JG, et al. Tallness and overweight during childhood have opposing effects on breast cancer risk. Br J Cancer 2001;85:1680-4.
5. Ahlgren M, Melbye M, Wohlfahrt J, Sorensen TI. Growth patterns and the risk of breast cancer in women. N Engl J Med 2004;351:1619-26.
6. Berkey CS, Frazier AL, Gardner JD, Colditz GA. Adolescence and breast carcinoma risk. Cancer 1999;85:2400-9.
7. Weiderpass E, Braaten T, Magnusson C, et al. A prospective study of body size in different periods of life and risk of premenopausal breast cancer. Cancer Epidemiol Biomarkers Prev 2004;13:1121-7.
8. Baer HJ, Colditz GA, Rosner B, et al. Body fatness during childhood and adolescence and incidence of breast cancer in premenopausal women: a prospective cohort study. Breast Cancer Res 2005;7:R314-25.
9. Brinton LA, Swanson CA. Height and weight at various ages and risk of breast cancer. Ann Epidemiol 1992;2:597-609.
10. Magnusson C, Baron J, Persson I, et al. Body size in different periods of life and breast cancer risk in post-menopausal women. Int J Cancer 1998;76:29-34.
11. Key T, Appleby P, Barnes I, Reeves G. Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst 2002;94:606-16.
12. Missmer SA, Eliassen AH, Barbieri RL, Hankinson SE. Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women. J Natl Cancer Inst 2004;96:1856-65.
13. Travis RC, Key TJ. Oestrogen exposure and breast cancer risk. Breast Cancer Res 2003;5:239-47.
14. Kaaks R, Berrino F, Key T, et al. Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC). J Natl Cancer Inst 2005;97:755-65.
15. Tworoger SS, Missmer SA, Eliassen AH, et al. The association of plasma DHEA and DHEA sulfate with breast cancer risk in predominantly premenopausal women. Cancer Epidemiol Biomarkers Prev 2006;15:967-71.
16. Eliassen AH, Missmer SA, Tworoger SS, et al. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women. J Natl Cancer Inst 2006;98:1406-15.
17. Bernstein L. Epidemiology of endocrine-related risk factors for breast cancer. J Mammary Gland Biol Neoplasia 2002;7:3-15.
18. Potischman N, Swanson CA, Siiteri P, Hoover RN. Reversal of relation between body mass and endogenous estrogen concentrations with menopausal status. J Natl Cancer Inst 1996;88:756-8.
19. Verkasalo PK, Thomas HV, Appleby PN, Davey GK, Key TJ. Circulating levels of sex hormones and their relation to risk factors for breast cancer: a cross-sectional study in 1092 pre- and postmenopausal women (United Kingdom). Cancer Causes Control 2001;12:47-59.
20. Lamar CA, Dorgan JF, Longcope C, Stanczyk FZ, Falk RT, Stephenson HE, Jr. Serum sex hormones and breast cancer risk factors in postmenopausal women. Cancer Epidemiol Biomarkers Prev 2003;12:380-3.
21. Key TJ, Appleby PN, Reeves GK, et al. Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst 2003;95:1218-26.
22. Westhoff C, Gentile G, Lee J, Zacur H, Helbig D. Predictors of ovarian steroid secretion in reproductive-age women. Am J Epidemiol 1996;144:381-8.
23. Genazzani AR, Pintor C, Corda R. Plasma levels of gonadotropins, prolactin, thyroxine, and adrenal and gonadal steroids in obese prepubertal girls. J Clin Endocrinol Metab 1978;47:974-9.
24. de Ridder CM, Bruning PF, Zonderland ML, et al. Body fat mass, body fat distribution, and plasma hormones in early puberty in females. J Clin Endocrinol Metab 1990;70:888-93.
25. de Ridder CM, Thijssen JH, Bruning PF, Van den Brande JL, Zonderland ML, Erich WB. Body fat mass, body fat distribution, and pubertal development: a longitudinal study of physical and hormonal sexual maturation of girls. J Clin Endocrinol Metab 1992;75:442-6.
26. Wabitsch M, Hauner H, Heinze E, et al. Body fat distribution and steroid hormone concentrations in obese adolescent girls before and after weight reduction. J Clin Endocrinol Metab 1995;80:3469-75.
27. van Hooff MH, Voorhorst FJ, Kaptein MB, Hirasing RA, Koppenaal C, Schoemaker J. Insulin, androgen, and gonadotropin concentrations, body mass index, and waist to hip ratio in the first years after menarche in girls with regular menstrual cycles, irregular menstrual cycles, or oligomenorrhea. J Clin Endocrinol Metab 2000;85:1394-400.
28. Obarzanek E, Kimm SY, Barton BA, et al. Long-term safety and efficacy of a cholesterol-lowering diet in children with elevated low-density lipoprotein cholesterol: seven-year results of the Dietary Intervention Study in Children (DISC). Pediatrics 2001;107:256-64.
29. Dietary intervention study in children (DISC) with elevated low-density-lipoprotein cholesterol. Design and baseline characteristics. DISC Collaborative Research Group. Ann Epidemiol 1993;3:393-402.
30. The Writing Group for the DISC Collaborative Research Group. Efficacy and safety of lowering dietary intake of fat and cholesterol in children with elevated low-density lipoprotein cholesterol. The Dietary Intervention Study in Children (DISC). JAMA 1995;273:1429-35.
31. Dorgan JF, Hunsberger SA, McMahon RP, et al. Diet and sex hormones in girls: findings from a randomized controlled clinical trial. J Natl Cancer Inst 2003;95:132-41.
32. Tanner JM. Growth at Adolescence. 2nd ed. Oxford (UK): Blackwell Scientific; 1962.
33. Dietz WH, Bellizzi MC. Introduction: the use of body mass index to assess obesity in children. Am J Clin Nutr 1999;70:123-5S.
34. Bellizzi MC, Dietz WH. Workshop on childhood obesity: summary of the discussion. Am J Clin Nutr 1999;70:173-5S.
35. Klein JP, Moeschberger ML. Survival analysis techniques for censored and truncated data. New York (NY): Springer-Verlag; 1997.
36. Kuczmarski RJ, Ogden CL, Grummer-Strawn LM, et al. CDC growth charts: United States. Adv Data; 2000. p. 1-27.
37. Willett WC. Anthropometric measures and body composition. 2nd ed. In: Willett WC, editor. Nutritional epidemiology. New York (NY): Oxford University Press; 1998. p. 244-72.
38. Willett WC, Stampfer MJ. Implications of total energy intake for epidemiologic analyses. 2nd ed. In: Willett WC, editor. Nutritional epidemiology. New York (NY): Oxford University Press; 1998.
39. McCartney CR, Prendergast KA, Chhabra S, et al. The association of obesity and hyperandrogenemia during the pubertal transition in girls: obesity as a potential factor in the genesis of postpubertal hyperandrogenism. J Clin Endocrinol Metab 2006;91:1714-22.
40. Stoll BA. Teenage obesity in relation to breast cancer risk. Int J Obes Relat Metab Disord 1998;22:1035-40.
41. Apter D, Butzow T, Laughlin GA, Yen SS. Metabolic features of polycystic ovary syndrome are found in adolescent girls with hyperandrogenism. J Clin Endocrinol Metab 1995;80:2966-73.
42. Caprio S, Hyman LD, Limb C, et al. Central adiposity and its metabolic correlates in obese adolescent girls. Am J Physiol 1995;269:E118-26.
43. Caprio S, Bronson M, Sherwin RS, Rife F, Tamborlane WV. Coexistence of severe insulin resistance and hyperinsulinaemia in preadolescent obese children. Diabetologia 1996;39:1489-97.
44. Stoll BA, Vatten LJ, Kvinnsland S. Does early physical maturity influence breast cancer risk?. Acta Oncol 1994;33:171-6.
45. Stoll BA. Western diet, early puberty, and breast cancer risk. Breast Cancer Res Treat 1998;49:187-93.
46. Guercio G, Rivarola MA, Chaler E, Maceiras M, Belgorosky A. Relationship between the growth hormone/insulin-like growth factor-I axis, insulin sensitivity, and adrenal androgens in normal prepubertal and pubertal girls. J Clin Endocrinol Metab 2003;88:1389-93.
47. Apter D. Hormonal events during female puberty in relation to breast cancer risk. Eur J Cancer Prev 1996;5:476-82.
48. Ibanez L, Potau N, Zampolli M, Rique S, Saenger P, Carrascosa A. Hyperinsulinemia and decreased insulin-like growth factor-binding protein-1 are common features in prepubertal and pubertal girls with a history of premature pubarche. J Clin Endocrinol Metab 1997;82:2283-8.
49. Ibanez L, de Zegher F, Potau N. Premature pubarche, ovarian hyperandrogenism, hyperinsulinism, and the polycystic ovary syndrome: from a complex constellation to a simple sequence of prenatal onset. J Endocrinol Invest 1998;21:558-66.
50. Pugeat M, Cousin P, Baret C, Lejeune H, Forest MG. Sex hormone-binding globulin during puberty in normal and hyperandrogenic girls. J Pediatr Endocrinol Metab 2000;13 Suppl 5:1277-9.
51. Ibanez L, Ong K, de Zegher F, Marcos MV, del Rio L, Dunger DB. Fat distribution in non-obese girls with and without precocious pubarche: central adiposity related to insulinaemia and androgenaemia from prepuberty to postmenarche. Clin Endocrinol (Oxf) 2003;58:372-9.
52. Apter D. Serum steroids and pituitary hormones in female puberty: a partly longitudinal study. Clin Endocrinol (Oxf) 1980;12:107-20.
53. Vihko R, Apter D. The role of androgens in adolescent cycles. J Steroid Biochem 1980;12:369-73.
54. Venturoli S, Fabbri R, Porcu E, et al. Endocrine and ovarian parameters at various frequencies of ovulation in adolescents. Arch Gynecol Obstet 1989;246:107-14.
55. Apter D, Vihko R. Endocrine determinants of fertility: serum androgen concentrations during follow-up of adolescents into the third decade of life. J Clin Endocrinol Metab 1990;71:970-4.
56. Rich-Edwards JW, Goldman MB, Willett WC, et al. Adolescent body mass index and infertility caused by ovulatory disorder. Am J Obstet Gynecol 1994;171:171-7.
57. Bulletti C, Jasonni VM, Naldi S, Cristiani P, Flamigni C. Reduced conversion of dehydroepiandrosterone into estrogens in premenarchal girls. J Endocrinol Invest 1986;9:375-81.
58. Winter JS, Faiman C. The development of cyclic pituitary-gonadal function in adolescent females. J Clin Endocrinol Metab 1973;37:714-8.
59. Penny R, Parlow AF, Olambiwonnu NO, Frasier SD. Evolution of the menstrual pattern of gonadotrophin and sex steroid concentrations in serum. Acta Endocrinol (Copenh) 1977;84:729-37.
60. Sperling MA, editor. Pediatric endocrinology. 2nd ed. Philadelphia (PA): W.B. Saunders Co.; 2002.
61. Alonso LC, Rosenfield RL. Oestrogens and puberty. Best Pract Res Clin Endocrinol Metab 2002;16:13-30.
62. Apter D, Vihko R. Serum pregnenolone, progesterone, 17- hydroxyprogesterone, testosterone, and 5α-dihydrotestosterone during female puberty. J Clin Endocrinol Metab 1977;45:1039-48.
63. Lemarchand-Beraud T, Zufferey MM, Reymond M, Rey I. Maturation of the hypothalamo-pituitary-ovarian axis in adolescent girls. J Clin Endocrinol Metab 1982;54:241-6.